Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NovoraySHSE:688300 -5.16%79 Piotroski F-Score is 7 as of Jul. 22, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates SHSE:688300 with a GF Score™ of 79/100 and a GF Value™ of ¥70.05 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,561 Chemicals companies, Novoray ranks better than 89.94% on this metric.
Good Sign:
Piotroski F-Score is 7, indicates a very healthy situation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Novoray has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
The historical rank and industry rank for Novoray's Piotroski F-Score or its related term are showing as below:
SHSE:688300'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 6 Max: 8
Current: 7
During the past 13 years, the highest Piotroski F-Score of Novoray was 8. The lowest was 3. And the median was 6.
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Novoray Piotroski F-Score Related Terms
Novoray Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Novoray's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688300 vs LIN, SHW, ECL: Piotroski F-Score Comparison
For the Specialty Chemicals subindustry, Novoray's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novoray Piotroski F-Score vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Novoray's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Novoray's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Novoray's current Net Income (TTM) was 301.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Novoray's current ratio of this year was 6.69379203. Novoray's current ratio of last year was 3.99657071.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Novoray's number of shares in issue this year was 238.788. Novoray's number of shares in issue last year was 242.453.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Novoray's gross margin of this year was 0.40507356. Novoray's gross margin of last year was 0.40366484.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Novoray's asset turnover of this year was 0.59537703. Novoray's asset turnover of last year was 0.55754031.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
0
+
0
+
1
+
1
+
1
+
1
=
7
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Novoray has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
Novoray (SHSE:688300) has a Piotroski F-Score of 7 as of Jul. 22, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Novoray and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Novoray's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Novoray ranks #157 out of 1561 companies in the Chemicals industry, placing it in the top 10.1%.
Is Novoray's Piotroski F-Score too high?
Novoray's current Piotroski F-Score of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Chemicals industry median Piotroski F-Score is 5.00. Novoray's value of 7 is 40% above this industry median. Based on the distribution chart, Novoray ranks #157 out of 1561 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Novoray has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Novoray's Piotroski F-Score compare to LIN and SHW?
According to the Chemicals industry distribution chart, Novoray ranks #157 out of 1561 companies for Piotroski F-Score. This places Novoray in the top 10% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Novoray's value of 7 is 40% above this benchmark. Historically, Novoray's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Novoray has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Chemicals company?
The median Piotroski F-Score among Chemicals companies is 5.00, based on 1,561 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novoray's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Novoray and its competitors. For the Chemicals industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novoray's current Piotroski F-Score is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novoray stock overvalued right now?
Based on GuruFocus' analysis, Novoray (SHSE:688300) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥70.05, compared to a current price of ¥128.32 — trading 83.2% above its estimated fair value. The current Piotroski F-Score is 7, which is 17% above median its 10-year median of 6.00 and 40% above the Chemicals industry median of 5.00. Novoray's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Novoray (SHSE:688300), the current Piotroski F-Score is 7 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novoray (SHSE:688300) Overvalued in 2026?
Based on GuruFocus' analysis, Novoray stock appears to be overvalued.
The current stock price of ¥128.32 is trading 83.2% above its estimated GF Value™ of ¥70.05.
GuruFocus considers Novoray to be Significantly Overvalued.
Key valuation signals for SHSE:688300:
Piotroski F-Score: 7 (17% above median its 10-year median of 6.00)
GF Value™: ¥70.05 vs. price of ¥128.32 (83.2% above fair value)
Industry Position: 40% above the Chemicals median (#157 of 1561)
No single metric tells the full story. See the SHSE:688300 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688300 has been successfully added to your 
